artificial intelligence
The digital pathology firm is working to further develop its diagnostic capabilities and broaden its menu of algorithms for different diseases.
Kiromic BioPharma Acquires InSilico Solutions
Kiromic expects the acquisition of the custom bioinformatics technology developer to facilitate new cancer immunotherapy discovery.
Inspirata Partners With UK Health Providers to Evaluate AI Software for Cancer Clinical Trials
The pilot programs will evaluate how artificial intelligence-based automation can improve matching patients with cancer to early-phase clinical trials.
Lantern Pharma Reacquires Irofulven From Allarity Therapeutics; Plans Bladder, Prostate Cancer Trial
In reacquiring the rights to the agent, which it out-licensed in 2015, Lantern is also gaining rights to Allarity's DRP technology to predict patients' responses.
Korean AI Pathology Startup Lunit Nabs $26M Investment from Guardant Health; Plans Collaboration
Having closed a Series C funding round, the firm is completing clinical validation, and will collaborate with Guardant to develop new precision oncology products.